CLINICAL TRIALS AT THE WINSHIP CANCER INSTITUTE

Leukemia Clinical Trials

Clinical trials are research studies conducted to evaluate new therapies. Such research relies on patients who volunteer to try the new or changed therapy. The purpose of these trials is to determine if a new treatment is safe, effective, and better than the standard of care.

Clinical trials are important, as they lead to tomorrow's standard of care. Advances in medicine and science result from new ideas developed through research. Risks and side effects exist with almost any treatment whether it is standard of care or clinical trial. However many safeguards are in place to make clinical trials as safe as possible. Before a drug is tested in patients, it is extensively studied in the laboratory and on animal models.

Any research conducted at Emory Winship Cancer Institute and Emory University must be approved by the Institutional (IRB). The IRB is made up of doctors from different specialties, ethicists, administrators, and members of the public. An IRB is required by the U.S. Food and Administration (FDA) to ensure protection of the rights and welfare of patients who are enrolled in clinical trials. Therefore, the IRB is authorized to review, require changes to, approve, or disapprove studies. Also, clinical trial patients are carefully monitored. Blood tests, x-rays, other procedures are performed regularly to detect and record any changes, good or bad, in the patient's condition. The monitoring provides scientists with valuable data for making patient care decisions and for documenting research results.

This is a summary of the clinical trials involving Leukemia at Winship Cancer Institute. If you have questions regarding a Leukemia trial, please call 404-778-3932.

• Leukemia Trials
• Bone Marrow Transplantation Trials

Back